Company / Net Income
Avantor Net Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$530.2M
FY2025
5-year range
-$530.2M / $711.5M
FY2021-FY2025
Trend
-174.5%
vs FY2024
Sector context
#156 of 164
Health Care
What the data says
Among 164 Health Care companies, Avantor is in the bottom 5% for net income. Net Income has fluctuated over the past 9 years, ranging from -$530M in FY2025 to $712M in FY2024.
Based on SEC 10-K filings.
-$530M in FY2025.
Declined from $321M to -$530M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 164This company -$530.2M Sector average $467.5M
▼
-213.4% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 174.5% year-over-year.
- Ranks #156 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$530.2M | -174.5% |
| FY2024 | $711.5M | +121.6% |
| FY2023 | $321.1M | +175.4% |
| FY2022 | $116.6M | -79.6% |
| FY2021 | $572.6M | +391.1% |
| FY2020 | $116.6M | +203.5% |
| FY2019 | -$112.7M | -29.7% |
| FY2018 | -$86.9M | +22.9% |
| FY2017 | -$112.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026